Cited by 224Tryptophan and brain disordersSchizophrenia research and treatmentImmunotoxicology and immune responses

Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis

Tourjman, Valérie, Kouassi, Édouard, Koué, Marie-Ève, Rocchetti, Matteo, Fortin-Fournier, Simon, Fusar-Poli, Paolo, Potvin, Stéphane·2013·Schizophrenia Research

Abstract

Objectives Evidence-based medicine suggests that schizophrenia is associated with an inflammatory syndrome, but the extent to which this syndrome is normalized by antipsychotic treatment has yet to be determined.Methods A systematic quantitative review of the effects of antipsychotics on peripheral cytokine levels in schizophrenia was performed, using follow-up studies providing in vivo cytokine assessments before and after treatment.Results We retrieved 23 studies (total of 762 subjects) which showed that antipsychotic treatment significantly increases plasma levels of soluble interleukin-2 receptor and reduces the plasma levels of interleukin-1β and interferon-γ.Conclusions These results show that antipsychotics produce anti-inflammatory effects in schizophrenia.

Integrity signals

Registry

Crossref · 10.1016/j.schres.2013.10.011

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tourjman, V., Kouassi, É., Koué, M.-È., Rocchetti, M., Fortin-Fournier, S., Fusar-Poli, P., & Potvin, S.
Affiliations
  • Université de Montréal (CA)
  • Hôpital Maisonneuve-Rosemont (CA)
  • King's College London (GB)
  • Institut universitaire en santé mentale de Montréal (CA)
Corresponding author
  • Kouassi, Édouard
  • Potvin, Stéphane
Venue
Schizophrenia Research
Publisher
Elsevier BV
Published
2013-12
Volume
151
Issue
1-3
Pages
43-47
ISSN
0920-9964 (ISSN-L)
OpenAlex
W2166043067
Cited by
224
References
45
Citations by year
2026: 12 · 2025: 8 · 2024: 12 · 2023: 27 · 2022: 15 · 2021: 20 · 2020: 15 · 2019: 16 · 2018: 19 · 2017: 18 · 2016: 26 · 2015: 21 · 2014: 15
FWCI
1.45
Type
journal article
Language
en
Open access
closed
Locations
  • Schizophrenia Research (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • Canadian Institutes of Health Research
  • Fonds de Recherche du Québec - Santé
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Keywords
antipsychotic drugs, schizophrenia
MeSH terms
Humans, Schizophrenia, Antipsychotic Agents, Databases, Bibliographic, Cytokines, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review